A purity number says the sample is clean. It does not say what the sample is. Those are separate questions answered by separate instruments, and the second one is answered by mass spectrometry. On a certificate of analysis the identity line is usually one observed mass compared with one theoretical mass, which makes it look trivial. Behind that single number sits a measurement worth understanding, because it is the only routine test that distinguishes one peptide from another.
Why chromatography alone cannot confirm identity
Reverse-phase HPLC separates by hydrophobicity and reports retention time. Retention time is a property of the method, not a fingerprint of the molecule. Two different peptides of similar length and composition can elute within seconds of each other on the same gradient. Sequence isomers, meaning peptides built from the same amino acids in a different order, can be almost impossible to separate.
The practical consequence is blunt. A chromatogram showing one sharp peak at 99.4 percent proves that whatever is in the vial is overwhelmingly one species. It does not prove that species is the one on the label. Our article on what HPLC purity measures covers the strengths of that method. This article covers the gap it leaves.
How the sample gets ionized
Mass spectrometers measure ions, not neutral molecules, so the first job is to give the peptide a charge and get it into the gas phase without tearing it apart. For peptides that is done with electrospray ionization. The eluent leaving the HPLC column is pushed through a fine capillary held at high voltage. The liquid emerges as a spray of charged droplets, the solvent evaporates, and the droplets shrink until charge density forces them to break up. What eventually enters the instrument is a bare peptide ion carrying one or more protons.
Electrospray is a soft ionization method: the peptide survives the transfer intact. That property made routine mass analysis of large biomolecules possible, and it is why the technique is coupled directly to liquid chromatography as LC-MS. The chromatograph separates and the spectrometer identifies.
Charge states and the m/z axis
The instrument does not report mass. It reports mass-to-charge ratio, written m/z. A peptide that has picked up three protons appears at roughly one third of its mass, shifted slightly by the mass of those protons. Because basic residues such as arginine and lysine each provide a site to hold a proton, a single peptide typically appears as a family of peaks at different charge states rather than as one line.
That family is a feature, not a nuisance. Each charge state is an independent estimate of the same underlying mass, and their spacing is itself diagnostic. A forty-four residue peptide such as tesamorelin will commonly show a cluster of three, four and five charge states.
Deconvolution: from a series of peaks to one mass
Deconvolution is the arithmetic that turns the charge-state series back into a single neutral mass. Software solves the set of simultaneous relationships across the observed peaks, works out which charge belongs to which peak, and reports one number. A clean deconvolution collapses the whole family into a single line.
Two masses can come out of that step and they are not interchangeable.
- Monoisotopic mass uses only the lightest isotope of each element. It is the sharp, precisely defined value and it is what high-resolution instruments report for peptides of ordinary size.
- Average mass weights each element by its natural isotope abundance. It is the value quoted on most product literature and it sits slightly higher than the monoisotopic mass. The gap widens with molecular size.
A certificate should say which convention it used. Comparing an observed monoisotopic mass against a theoretical average mass will look like an error of several daltons when nothing is wrong.
Observed versus theoretical
The theoretical mass is calculated from the sequence, summing residue masses and adding water for the terminal groups, then adjusting for any modification such as acetylation, amidation or a fatty acid chain. The observed mass is what the instrument measured. The certificate reports both. On a modern high-resolution instrument, agreement well inside one dalton is expected for a peptide in this size range, and low parts-per-million agreement is routine.
Modified peptides are where care is needed. Semaglutide carries two substitutions and a C18 fatty diacid on a linker. The theoretical mass must include that whole construct. A calculation done on the bare backbone will disagree with the instrument by the mass of the side chain, and the disagreement is arithmetic rather than a quality finding.
Reading a mass shift
When the observed mass differs from theory by a consistent, recognizable amount, the size of the gap names the problem.
| Shift | Most likely cause | Comment |
|---|---|---|
| +16 | Oxidation, usually of methionine, sometimes tryptophan | One added oxygen. Common storage and handling artifact |
| +32 | Double oxidation | Two sites, or a sulfone |
| -18 | Loss of water, dehydration or intramolecular condensation | Aspartimide formation is a frequent synthesis route to this |
| +1 | Deamidation of asparagine or glutamine | Strictly +0.984, which a high-resolution instrument resolves cleanly |
| +42 | Acetylation | Intended if the sequence is N-terminally acetylated, unintended otherwise |
| -17 | Loss of ammonia, often pyroglutamate formation at an N-terminal Gln | Frequent in peptides beginning with glutamine |
| Exactly one residue mass | A deletion sequence from an incomplete coupling | Identifies which residue was missed |
A methionine-containing compound such as SS-31 is a reasonable candidate for the +16 species, which is one reason oxidation-prone peptides are stoppered under nitrogen and stored cold.
MS/MS sequencing, the definitive answer
Intact mass confirms that the molecular formula matches. It does not prove the residues are in the right order, because rearranging a sequence does not change its mass. Tandem mass spectrometry closes that hole. The instrument isolates the peptide ion, fragments it by collision with an inert gas, and measures the pieces. Peptide backbones break preferentially at the amide bond, producing ladders of fragments that differ by one residue at a time. Reading the mass differences along a ladder reads the sequence.
MS/MS is the gold standard for identity and it is not run on every routine lot release, because intact mass plus a clean chromatogram answers the ordinary question. It is the right test when a sequence is genuinely in question, when two candidate compounds share a formula, or when an unexpected mass needs to be pinned down. The impurities it finds trace directly back to how the peptide was synthesized.
What to ask for on a certificate
- The ionization method and the instrument type.
- Whether the reported mass is monoisotopic or average.
- Theoretical mass alongside observed mass, not observed alone.
- The spectrum itself, or at least the deconvoluted mass, rather than a bare pass or fail.
Every lot across the research peptide catalogue is tested by an independent laboratory for HPLC purity and mass-spectrometric identity before release, and the lot number on the vial maps to that certificate. The line-by-line walkthrough is in how to read a peptide COA.
Frequently asked questions
Why does the observed mass sit a fraction of a dalton off from theory?
Instruments have a stated accuracy, and small deviations inside that window are normal. What matters is whether the gap is random noise or a recognizable shift such as sixteen or eighteen daltons.
Is mass spectrometry quantitative for purity?
Not straightforwardly. Different species ionize with different efficiency, so peak intensity is a poor proxy for abundance. Purity is measured by chromatography, identity by mass spectrometry, and the two belong on the same certificate.
Can mass spectrometry tell the difference between two peptides with the same formula?
Intact mass cannot, because their masses are identical. MS/MS fragmentation can, because the fragment ladders differ.
References
- Fenn JB, et al. 1989. Electrospray ionization for mass spectrometry of large biomolecules. Science.
- Mann M, Meng CK, Fenn JB. 1989. Interpreting mass spectra of multiply charged ions. Analytical Chemistry.
- Steen H, Mann M. 2004. The ABC's and XYZ's of peptide sequencing. Nature Reviews Molecular Cell Biology.
- Aebersold R, Mann M. 2003. Mass spectrometry-based proteomics. Nature.
- Eggen I, et al. 2014. Impurities in peptide drug substances: identification, control and analytical strategies. Journal of Peptide Science.
Research use only. This article is analytical background for laboratory researchers. Homegrown Peptides products are not for human or animal use, are not drugs, and nothing here is medical advice.
